Browse 349 uterine cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.
Endometrial cancer, which starts in the lining of the uterus, is the most common gynecologic cancer in the United States and one of the few cancers whose death rate has been rising. The most common early warning sign is bleeding after menopause, which is why it is often found early and treated with surgery. Research matters most for cancer that returns or has spread, where immunotherapy combined with chemotherapy became a standard first treatment only in the past few years, and trials are testing new targeted drugs matched to the tumor's genetic profile.
Location: Boston MA, New Haven CT, Lake Success NY, New York NY,
Sponsor: Pheast Therapeutics
Sex: All
Age: 18+
Code: NCT06840886
Phase 1, Recruiting
Active & Responsive
A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer
for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Upland CA, Irvine CA, Lancaster CA, Duarte CA,
Sponsor: City of Hope Medical Center
Sex: Female
Age: 18+
Code: NCT07741968
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Clonal Hematopoiesis Chemotherapy and Radiation Effects Study
for
Lung Cancer (Diagnosis), Osteochondroma, Spitz Nevus,
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute
Sex: All
Age: 18+
Code: NCT07675967
Recruiting
Active & Responsive
177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
for
Castration-Resistant Prostate Cancer (CRPC), Colorectal Cancer,
Location: Dothan AL, Grand Rapids MI, Omaha NE, Houston TX
Sponsor: Radiopharm Theranostics, Ltd
Sex: All
Age: 18+
Code: NCT07189871
Phase 1, Phase 2, Recruiting
Active & Responsive
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
for
Triple Negative Breast Cancer, HER2-negative Breast Cancer,
Location: Fairfax VA, Orlando FL, Huntersville NC, Sarasota FL,
Sponsor: Dren Bio
Sex: All
Age: 18+
Code: NCT06999187
Phase 1, Recruiting
Active & Responsive
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
for
Breast Cancer, Endometrial Cancer, Ovarian Cancer,
Location: Boston MA, Fairfax VA, Orlando FL, Cleveland OH,
Sponsor: Terremoto Biosciences Inc.
Sex: All
Age: 18+
Code: NCT07109726
Phase 1, Phase 2, Recruiting
Active & Responsive
HPV DNA Vaccine Via Electroporation for HPV16 Positive Cervical Neoplasia
for
Human Papillomavirus Type 16,
Location: Baltimore MD, Birmingham AL
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sex: Female
Age: 19+
Code: NCT04131413
Phase 1, Recruiting
Active & Responsive
A Phase 1b, Open-Label Study Of REC-617, A Selective CDK7 Inhibitor, In Patients With Metastatic Or Unresectable RB1-Negative Leiomyosarcoma After Prior Systemic Therapy
for
Phase 1b, Open Label, REC-617, RB1-Negative, Leiomyosarcoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT07633756
Phase 1, Recruiting
Active & Responsive
IGFBP-2 Vaccine to Prevent Ovarian Cancer Progression in Patients With Serologic Detection of Recurrence
for
Fallopian Tube Carcinoma, Ovarian Carcinoma,
Location: Seattle WA
Sponsor: University of Washington
Sex: Female
Age: 18+
Code: NCT07495124
Phase 2, Recruiting
Active & Responsive
DBC-664 in Adult Patients With Solid Tumors
for
Malignant Germ Cell Tumor, Lung Adenocarcinoma,
Location: Lake Success NY, East Brunswick NJ, Grand Rapids MI,
Sponsor: Duboce Biopharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT07705035
Phase 1, Recruiting
New
A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies
for
Advanced Solid Tumors, Colorectal Cancer (CRC),
Location: Boston MA, New York NY, Hackensack NJ, Philadelphia PA,